Acute cerebellitis following SARS‐CoV‐2 infection: A case report and review of the literature

Novel coronavirus disease (COVID‐19) first described in Wuhan, China in December 2019, has rapidly spread across the world and become a global public health emergency. Literature on the neurological manifestations of COVID‐19 is limited. We report a 24‐year‐old male, who presented with vertigo, dysa...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Medical Virology 2021-12, Vol.93 (12), p.6818-6821
Main Authors: Moreno‐Escobar, Maria Camila, Feizi, Parissa, Podury, Sanjiti, Tandon, Medha, Munir, Badria, Alvi, Muhammad, Adcock, Amelia, Sriwastava, Shitiz
Format: Article
Language:English
Subjects:
Case reports
cerebellitis
Coronaviruses
COVID-19
Intravenous administration
Literature reviews
Magnetic resonance imaging
Polymerase chain reaction
Public health
Reverse transcription
SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2
Short Communication
Signs and symptoms
Vertigo
Viral diseases
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Novel coronavirus disease (COVID‐19) first described in Wuhan, China in December 2019, has rapidly spread across the world and become a global public health emergency. Literature on the neurological manifestations of COVID‐19 is limited. We report a 24‐year‐old male, who presented with vertigo, dysarthria, and bradyphrenia 3 weeks after being diagnosed with COVID‐19 on nasopharyngeal reverse transcription polymerase chain reaction. The patient was diagnosed with acute cerebellitis based on magnetic resonance imaging features and showed improvement posttreatment with intravenous methylprednisone for 5 days. The scope of this article is to highlight the importance of early identification of neurological symptoms and timely management as the outcomes may be catastrophic.
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.27232